Alkem unveils Cetuximab under the Brand Name Cetuxa in India Dr. Nandita Mohan31 May 2023 11:23 AM ISTMumbai: One of India's leading drug makers, Alkem Labs, has announced the launch of the world's first Cetuximab biosimilar in the country under the...
Alkem Launches Cetuximab under the Brand Name Cetuxa in India Dr. Nandita Mohan30 May 2023 11:51 AM ISTMumbai: One of India's leading drug makers, Alkem Labs, has announced the launch of the world's first Cetuximab biosimilar in the country under the...
The Future of the Pharmaceutical Industry - Biopharmaceuticals and Patient Centric Approach in Marketing Vivek Hattangadi29 Aug 2022 11:54 AM ISTOn 23rd August 2022, I was reading the thoughts of G. V. Prasad (Managing Director and Co-chairman DRL) in an interview with McKinsey. It is ...
Understanding the Scope of Biosimilars in India with Dr. Manish Adhia Dr. Manish Adhia2 Aug 2022 11:12 AM ISTThe pharmaceutical industry globally is seeing a major shift from small molecules (chemical entity drugs) to the more complex biologics and...
Biocon targets emerging, developed markets with biosimilars Meghna A Singhania23 Oct 2015 8:38 AM ISTNEW DELHI: Biopharmaceuticals firm Biocon is looking to tap opportunities in biosimilars targeting diseases such as diabetes and cancer among others,...
India risks missing boat as biosimilars shake up drug industry Meghna A Singhania15 Oct 2015 2:10 PM ISTIndia, which has dominated the generic drugs industry for decades, is falling behind in the race to make copies of complex biotech drugs, which are...
Suffix to distinguish biosimilars now Pooja Bhatia Bhatia28 Aug 2015 1:04 PM ISTCopies of biologic products knows as biosimilars will now have suffix to their names to distinguish them from their branded counterparts says...
